Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Warner-Lambert Co.
Silver Linings: COVID-19 Creates Investment Bubble, Golden R&D Era
A choice asset in the middle of a pandemic, pharma companies could see the investment bubble burst once normalcy is on the horizon. But interest will continue in innovators, rather than big pharma specifically, predicts an expert panel featuring Biogen's chairman, a former Sanofi CEO and an ex-NIH director.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.